3-D Matrix, Ltd.

$2.96

$0.21(-6.73%)

3-D Matrix, Ltd.

7777.T

$2.96

$0.21(-6.73%)

3-D Matrix, Ltd.

7777.T

JPX

$2.96

$0.21(-6.73%)

Chart

Upcoming Earnings

Next report date

Jun 11, 2026

Report period

Q2 2026

EPS Estimate

—

Revenue Estimate

—

Key stats

52-Week Range$2.96

$0.64

$3.37

Market capitalization

$348.27M

Dividend yield (indicated)

0.00%

Price to earnings Ratio (TTM)

15,223.32

Basic EPS (TTM)

$-0.06

Net income (TTM)

$-5.93M

Revenue (TTM)

$47.82M

Avg. volume

6.25M

Beta (1Y)

0.52

Employees

106

Market capitalization

$348.27M

Dividend yield (indicated)

0.00%

Price to earnings Ratio (TTM)

15,223.32

Basic EPS (TTM)

$-0.06

Net income (TTM)

$-5.93M

Revenue (TTM)

$47.82M

Avg. volume

6.25M

Beta (1Y)

0.52

Employees

106

Screener Quick Check

About 3-D Matrix, Ltd.

Sector

Healthcare

Industry

Medical - Devices

CEO

Jun Okada

Website

www.3d-matrix.co.jp

Headquarters

Kojimachi HF Building, Tokyo, 102-0083

IPO Date

2011-10-24

Identifiers

ISINJP3410730000

Description

3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use...

Related Stocks

YAKUODO HOLDINGS Co., Ltd.

7679.T

$1,976.00Mkt Cap: $38.44B

Healthcare

Medical - Pharmaceuticals

ISIN:JP3931410009

Fuji Pharma Co., Ltd.

4554.T

$13.83Mkt Cap: $338.34M

Healthcare

Drug Manufacturers - Specialty & Generic

ISIN:JP3816200004

Dividend Overview

This company does not pay dividends

Financials

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate